Gerard Brophy, EVP, Biopharma Production at Avantor, Inc. (AVTR), sold 757,160 shares at $30.08 ($22.8M) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Open-market sale of $22.8M AVTR by EVP, Biopharma Production. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 162,248 | $4.9M | 21.4% |
| 2 | $30.04 | 162,248 | $4.9M | 21.4% |
| 3 | $30.08 | 216,332 | $6.5M | 28.6% |
| 4 | $30.08 | 216,332 | $6.5M | 28.6% |
| Total | $30.06 avg | 757,160 | $22.8M | 100% |
| Filing → |
| AVTR | SELL | 2023-02-02 | $568K | — | Filing → |
| AVTR | SELL | 2022-05-23 | $1.2M | — | Filing → |
| AVTR | SELL | 2022-03-02 | $140K | — | Filing → |